Video

Samuele Cortese, MD: COVID-19 Offers Opportunity for ADHD Patients

Author(s):

Dr. Cortese explains how more data could improve ADHD care.

The ongoing coronavirus disease 2019 (COVID-19) pandemic might change exactly how attention deficit/hyperactivity disorder (ADHD) is treated.

With many students forced to go to school over the computer and workers across the globe forced to work from home there undoubtedly will be some challenges and struggles for this patient population.

In an interview with HCPLive®, Samuele Cortese, MD, PhD, Professor of Child and Adolescent Psychiatry, University of Southampton, explained what he thinks will be some issues moving forward for ADHD patients and how doctors can handle some of the challenges linked to the pandemic.

Cortese said the pandemic has strengthened the idea there is a patient’s quality of life could substantially improve if ADHD is treated correctly. He said the cognitive symptoms must be first and foremost in crafting an individual treatment plan and by doing so doctors can improve the other aspects of the patient’s life.

One bright spot of the pandemic, Cortese said, is that there will be more data available on what ADHD patients are facing and struggling with.

Related Videos
Jonathan Meyer, MD: Cognitive Gains, Dopamine-Free Schizophrenia Treatment with Xanomeline Trospium Chloride
Chelsie Monroe: Challenges Clinicians Should Consider When Prescribing Muscarinic Modulators for Schizophrenia
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Thumbnail for schizophrenia special report around approval of Cobenfy.
Developing Risk Assessment Tools for Viruses in School
© 2024 MJH Life Sciences

All rights reserved.